What is the appropriate dosage, safety profile, and contraindications for quercetin 500 mg in a healthy adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Quercetin 500 mg Dosing and Safety

Quercetin 500 mg daily is safe for healthy adults based on extensive human trials, with doses up to 1000 mg/day well-tolerated for up to 12 weeks, though long-term safety data beyond 3 months at high doses remains limited. 1, 2, 3

Appropriate Dosage

The evidence supports the following dosing framework:

  • Standard supplemental dose: 500-1000 mg/day is the most studied range in healthy adults 2, 3, 4
  • Duration studied: Up to 12 weeks is well-documented; data beyond this timeframe is insufficient 5
  • Dose-response effects: Benefits (particularly blood pressure reduction) appear more consistent at ≥500 mg/day compared to lower doses 6
  • Maximum studied dose: Up to 1000 mg/day in large trials (n=1,002 subjects) showed negligible adverse effects 3

The FDA-labeled product indicates dosing as needed rather than continuous daily use 1, though research trials used consistent daily dosing.

Safety Profile

Well-Tolerated Effects

Large-scale human studies demonstrate excellent short-term safety:

  • Minimal adverse effects: In a trial of 1,002 adults taking 500-1000 mg/day for 12 weeks, adverse effects were rarely reported and mild when present 3, 5
  • No oxidative stress concerns: Despite theoretical antioxidant benefits, quercetin supplementation did not alter plasma oxidative stress markers (F2-isoprostanes, oxidized LDL) or antioxidant capacity (FRAP, ORAC) 4
  • Metabolic effects: Modest reductions in systolic blood pressure (3-4 mm Hg) and diastolic blood pressure (2-3 mm Hg) at doses ≥500 mg/day 6
  • Gastrointestinal effects: Occasional nausea, vomiting, diarrhea, or anorexia reported but uncommon 7

Critical Safety Gaps and Precautions

Long-term safety (>12 weeks) at doses ≥1000 mg/day lacks adequate human data 5. Animal studies reveal concerning patterns that warrant caution:

  • Nephrotoxicity risk: Quercetin may enhance kidney damage in pre-existing renal impairment 5
  • Hormetic dose-response: Recent animal data (2026) shows dose-dependent organ injury at higher doses, with tissue damage occurring despite normal serum biomarkers—indicating conventional lab tests may miss early structural injury 8
  • Potential tumor promotion: Animal studies suggest possible enhancement of estrogen-dependent cancers 5
  • Drug interactions: Quercetin alters bioavailability of certain medications through metabolic interference 5

Contraindications and High-Risk Groups

Absolute Cautions

  • Pregnancy and breastfeeding: Use only after consulting healthcare provider 1
  • Pre-existing kidney disease: Avoid due to potential nephrotoxic enhancement 5
  • Estrogen-dependent cancers: Theoretical risk based on animal data 5
  • Concurrent medications: Particularly those metabolized via pathways quercetin affects 5

Relative Cautions

  • Children: Safety data insufficient; keep out of reach 1
  • Prolonged use: Do not use for headache pain >7 days without medical consultation 1
  • New or worsening symptoms: Discontinue and seek medical evaluation 1

Clinical Context

The disconnect between quercetin's robust preclinical effects and modest human outcomes is notable. While animal and cell studies show impressive anti-inflammatory, antioxidant, and metabolic benefits 9, 10, 11, human trials reveal:

  • Negligible impact on inflammatory markers (C-reactive protein, cytokines) except slight IL-6 reduction at 1000 mg/day 3
  • No effect on oxidative stress biomarkers despite theoretical antioxidant properties 4
  • Minimal metabolic changes: Small improvements in blood pressure and kidney function (creatinine, GFR), but no consistent effects on lipids, glucose, or body weight 3

This suggests either poor bioavailability, rapid metabolism, or that serum markers inadequately reflect tissue-level effects—the latter supported by recent findings that tissue injury can occur without serum biomarker changes 8.

Practical Recommendations

For a healthy adult considering quercetin 500 mg:

  1. Safe for short-term use (up to 12 weeks) at 500-1000 mg/day
  2. Screen for kidney disease before initiating
  3. Avoid in pregnancy without medical guidance
  4. Monitor for drug interactions if taking other medications
  5. Discontinue if symptoms persist or worsen beyond 7 days
  6. Do not exceed 1000 mg/day without medical supervision
  7. Avoid long-term continuous use (>3 months) until more safety data emerges

The evidence supports quercetin 500 mg as safe for healthy adults in the short term, but the narrow therapeutic window suggested by animal studies and lack of long-term human data necessitate conservative use 5, 8.

References

Research

Safety Aspects of the Use of Quercetin as a Dietary Supplement.

Molecular nutrition & food research, 2018

Guideline

espen micronutrient guideline.

Clinical Nutrition, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.